Agilent to Acquire North American CDMO BIOVECTRA
July 23, 2024
July 23, 2024
SANTA CLARA, California, July 23 -- Agilent Technologies, a company that specializes in life sciences, diagnostics and applied chemical markets, issued the following news release:
* * *
Expands Agilent's end-to-end biopharma solutions that accelerate drug discovery, development, and manufacturing
* * *
Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract de . . .
* * *
Expands Agilent's end-to-end biopharma solutions that accelerate drug discovery, development, and manufacturing
* * *
Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract de . . .